USANA Health Sciences (USNA) Stock Price, News & Analysis

Company Overview

USANA Health Sciences, Inc. develops and sells nutritional supplements, personal-care products and foods designed to support general health and wellness. Its product portfolio includes vitamins and mineral supplements, herbal and specialty nutritional products, meal-replacement and snack items, and skincare products marketed under the USANA and Sensé brands.

Founded in 1992 by immunologist Myron Wentz, USANA distributes its products primarily through a direct-selling model involving independent associates. The company sells products directly to consumers through its e-commerce platforms and serves markets across North America, Asia-Pacific and other international regions.

USANA is headquartered in Salt Lake City, Utah. Its business focuses on research, formulation, manufacturing and distribution of wellness products, with manufacturing operations and quality-control processes supporting its global product portfolio.

Key Stats

• Today's Range: $14.57 to $14.95
• 50-Day Range: $12.79 to $23.22
• 52-Week Range: $12.57 to $27.25
• Volume: 163,725 shs
• Average Volume: 180,654 shs
• Market Capitalization: $273.37 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

USANA Health Sciences Stock Analysis - MarketRank™

USANA Health Sciences scored higher than 21% of companies evaluated by MarketBeat, and ranked 143rd out of 167 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.9 / 5
• Analyst Rating: Sell

Consensus Rating

USANA Health Sciences has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 2 sell ratings.

Amount of Analyst Coverage

USANA Health Sciences has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 132.89%

Earnings Growth

Earnings for USANA Health Sciences are expected to grow by 132.89% in the coming year, from $0.76 to $1.77 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of USANA Health Sciences is -12.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of USANA Health Sciences is -12.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Growth Ratio

USANA Health Sciences has a PEG Ratio of 1.62. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

USANA Health Sciences has a P/B Ratio of 0.51. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.12% of the float of USANA Health Sciences has been sold short.

Short Interest Ratio / Days to Cover

USANA Health Sciences has a short interest ratio ("days to cover") of 3.36, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in USANA Health Sciences has recently increased by 16.88%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

USANA Health Sciences does not currently pay a dividend.

Dividend Growth

USANA Health Sciences does not have a long track record of dividend growth.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 2 news articles for USANA Health Sciences this week, compared to 3 articles on an average week.

MarketBeat Follows

Only 1 people have added USANA Health Sciences to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, USANA Health Sciences insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.82% of the stock of USANA Health Sciences is held by insiders.

Percentage Held by Institutions

54.25% of the stock of USANA Health Sciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/04/2026
• Today: 10/06/2026
• Next Earnings (Estimated): 10/28/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Consumer Staples
• Industry: Personal Care Products
• Sub-Industry: Personal Care Products
• Current Symbol: NYSE:USNA
• CIK: 896264
• Web: www.usana.com
• Phone: (801) 954-7100
• Fax: 801-954-7300
• Employees: 1,570
• Year Founded: 1992

Profitability

• EPS (Trailing Twelve Months): ($1.21)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 19.47
• P/E Growth: 1.62
• Net Income: $10.76 million
• Net Margins: -2.43%
• Pretax Margin: 0.28%
• Return on Equity: 3.41%
• Return on Assets: 2.50%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.66
• Quick Ratio: 1.84

Sales & Book Value

• Annual Sales: $913.36 million
• Price / Sales: 0.30
• Cash Flow: $4.12 per share
• Price / Cash Flow: 3.59
• Book Value: $29.16 per share
• Price / Book: 0.51

Miscellaneous

• Outstanding Shares: 18,477,000
• Free Float: 18,325,000
• Market Cap: $273.37 million
• Optionable: Optionable
• Beta: 0.68